A Three-Month Washout Is a Risk Marker, Not a Safety Threshold, Before Adjuvant Osimertinib

Journal of Thoracic Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles